Blaney receives award from National Cancer Institute

March 27, 2018

Dr. Susan Blaney, deputy director of Texas Children’s Cancer and Hematology Centers, recently received a Director’s Service Award from the National Cancer Institute for her outstanding and dedicated service to the Institute and the Clinical Trials and Translational Research Advisory Committee from 2015 to 2017.

Blaney is the vice chair of the Children’s Oncology Group, the National Cancer Institute (NCI) supported clinical trials group and the world’s largest organization devoted exclusively to pediatric cancer research.

Blaney served as the co-director of the Developmental Therapeutics Program at Texas Children’s Cancer Center where she performs pre-clinical and clinical studies of new antineoplastic agents. A primary focus of her research is the development of new drugs for the treatment of central nervous system tumors in children with a particular emphasis on the development of new agents for intrathecal administration.

For more information about Dr. Susan Blaney, visit